Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 600mg/200mg/300mg

Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets 600mg/200mg/300mg Technical Specification:

GENERIC NAME OF THE MEDICINAL PRODUCT:

• Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (600mg/200mg/300mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

• Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (600mg/200mg/300mg)
  Composition:
  Each film-coated tablet contains:
  Efavirenz …………………….….600mg
  Emtricitabine ……………………200mg
  Tenofovir Disoproxil………….245mg
  (Equivalent to 300mg of Tenofovir Disoproxil Fumarate or 136mg of Tenofovir).
  Excipients…………………………. 76mg
  Lactose (as monohydrate)
  Colours: Titanium Dioxide USP

THERAPEUTIC INDICATIONS:

The indication applied is for the use of Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva in the treatment of Human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years and over with virologic suppression to HIV-1 RNA levels of < 50 copies/ml on their current combination antiretroviral therapy.
Treat and prevent HIV/AIDS Immunodeficiency Virus (HIV).
Nucleoside and Nucleotide reverse transcriptase inhibitors.

CAUTION & WARNING:

CAUTION: Do not throw away consumer package insert.
Swallow whole do not chew or crush.
Keep the container tightly closed.
WARNING: Do not skip/discontinue the dose for effective treatment.
Do not stop taking your medicine or change your dosage without consulting your doctor.
Suitable for Vegetarians & Vegans.
Efavirenz, Emtricitabine and Tenofovir should not be used to treat hepatitis B virus infection (HBV; an ongoing liver infection).
Keep out of the reach and sight of children.

STORAGE & DOSAGE:

Storage:  Store protected from moisture at a temperature not exceeding 30°C.
Dosage: As directed by the Physician.  

Why Taj Pharmaceuticals?

Taj Pharmaceuticals is your trusted source for Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets, a powerful combination for HIV treatment. Our unwavering commitment to pharmaceutical excellence ensures that every tablet meets stringent global standards for safety and efficacy. At Taj Pharmaceuticals, we recognize the importance of affordability in healthcare. Our dedication to offering cost-effective medications ensures that individuals living with HIV have access to the most effective treatments, regardless of their economic circumstances. Innovation is at the heart of our mission. We continuously strive to enhance drug formulations, improve patient outcomes, and minimize side effects. Our research and development efforts focus on advancing treatment options to provide you with the best possible care while managing HIV. Choose Taj Pharmaceuticals for Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets, and experience pharmaceutical excellence that prioritizes your well-being. We stand by your side in the fight against HIV, offering quality and affordability to enhance your overall health and quality of life.

What is Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets and its uses:

Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets are a combination medication used in the treatment of HIV (human immunodeficiency virus) infection. This combination tablet contains three different antiretroviral drugs, each with a specific role in inhibiting the replication of the HIV virus. Here’s an overview of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets and their primary uses:

• Composition:
  Efavirenz: It is a nonnucleoside reverse transcriptase inhibitor (NNRTI). Efavirenz works by inhibiting the action of the reverse transcriptase enzyme, which is essential for HIV replication.
  Emtricitabine: Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI). It interferes with the reverse transcription process, preventing the virus from converting its RNA into DNA within host cells.
  Tenofovir Disoproxil Fumarate: This is another NRTI that also targets HIV’s reverse transcriptase enzyme. It is converted into its active form, tenofovir, in the body.
• Primary Use:
  Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets are used in the treatment of HIV infection. They are part of a combination antiretroviral therapy (ART) regimen, which typically includes multiple drugs from different classes.
  The primary goal of this combination medication is to suppress HIV replication in the body, reduce the viral load to undetectable levels, preserve immune function, and slow the progression of HIV disease.
• Pre-Exposure Prophylaxis (PrEP):
  This combination is also used as PrEP in individuals who are at high risk of contracting HIV. When taken consistently and as prescribed, it can significantly reduce the risk of HIV infection.
• Post-Exposure Prophylaxis (PEP):
  In some cases, such as after potential exposure to HIV through unprotected sex or needlestick injuries, this medication may be prescribed as PEP. PEP is a short-term course of antiretroviral drugs taken after potential exposure to prevent HIV infection.
• Prevention of Mother-to-Child Transmission (PMTCT):
  Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets may be used as part of PMTCT programs to reduce the risk of transmitting HIV from an HIV-positive pregnant woman to her baby during childbirth or breastfeeding.

It’s important to note that these tablets are not a cure for HIV, and they do not eliminate the virus from the body. Instead, they are a critical component of HIV management, helping individuals living with HIV lead healthier lives, reduce the risk of transmitting the virus, and improve overall health outcomes when used as part of a comprehensive antiretroviral treatment regimen. The specific combination of drugs and treatment plan can vary depending on individual factors and the stage of HIV infection, so it’s essential for individuals with HIV to work closely with their healthcare provider.

How Does Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets Work?

Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets work as antiretroviral medications to inhibit the replication of the HIV (human immunodeficiency virus) within the body. This combination tablet contains three different drugs, each with a specific mechanism of action that targets various stages of the HIV life cycle. Here’s how Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets work:

• Efavirenz:
  Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI).
  HIV is a retrovirus that converts its RNA genetic material into DNA using an enzyme called reverse transcriptase. This DNA is then integrated into the host cell’s DNA.
  Efavirenz binds to the reverse transcriptase enzyme and inhibits its activity. By doing so, it prevents the conversion of HIV’s RNA genome into DNA.
  Without the formation of viral DNA, HIV cannot integrate into the host cell’s DNA, and the virus’s replication process is disrupted.
• Emtricitabine:
  Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI).
  It interferes with the reverse transcription process that HIV uses to convert its RNA genome into DNA.
  Emtricitabine mimics one of the building blocks of DNA, known as a nucleoside. When incorporated into the growing viral DNA chain, it acts as a “chain terminator,” preventing the addition of more DNA building blocks.
  This interruption in DNA synthesis hinders the virus from replicating its genetic material.
• Tenofovir Disoproxil Fumarate:
  Tenofovir Disoproxil Fumarate (TDF) is another nucleoside reverse transcriptase inhibitor (NRTI).
  Once inside the body, TDF is converted into its active form, tenofovir.
  Tenofovir works similarly to Emtricitabine by competing with the natural building blocks of DNA during viral replication.
  When tenofovir is incorporated into the viral DNA chain, it disrupts its elongation and causes premature termination, preventing the completion of the viral DNA.

Together, the three drugs in this combination tablet act synergistically to target different stages of HIV replication. Efavirenz inhibits the early stages of reverse transcription, while Emtricitabine and Tenofovir Disoproxil Fumarate act on the elongation phase of viral DNA synthesis. By interfering with these crucial steps, these medications effectively suppress the replication of HIV in the body. It’s important to note that Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets do not cure HIV; they are part of a lifelong treatment regimen aimed at controlling the virus and preserving immune function. Maintaining consistent and proper dosing is essential to their effectiveness in managing HIV. These tablets are typically used in combination with other antiretroviral drugs to maximize their effectiveness and minimize the risk of developing drug resistance.

Benefits of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets:

• Effective HIV Suppression: These tablets are highly effective at suppressing HIV replication in the body, leading to a reduction in the viral load. This is critical for preserving immune function and slowing the progression of HIV disease.
• Convenience: The combination of three drugs in a single tablet simplifies the treatment regimen for individuals living with HIV. It reduces the number of pills that need to be taken each day, improving adherence to treatment.
• Prevention of Transmission: When used as pre-exposure prophylaxis (PrEP), these tablets can significantly reduce the risk of HIV infection in individuals at high risk, such as those in serodiscordant relationships or engaging in high-risk behaviors.
• Well-Tolerated: In comparison to some other antiretroviral medications, Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets are generally well-tolerated, with a lower incidence of severe side effects.
• Improvement in Quality of Life: By controlling HIV replication, these tablets can lead to an improved quality of life for individuals living with HIV. They reduce the frequency of opportunistic infections, improve overall health, and increase life expectancy.

Side Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets:

• Central Nervous System (CNS) Effects: Efavirenz, one of the components, can cause CNS side effects such as vivid dreams, dizziness, sleep disturbances, and mood changes, especially during the initial weeks of treatment.
• Nausea and Gastrointestinal Issues: Some individuals may experience mild gastrointestinal symptoms such as nausea, diarrhea, or abdominal discomfort.
• Renal (Kidney) Effects: Tenofovir, one of the components, can affect kidney function in some individuals. Regular monitoring of kidney function is essential.
• Bone Density: Long-term use of tenofovir may lead to reduced bone mineral density in some people, potentially increasing the risk of fractures.
• Lactic Acidosis: Although rare, a severe condition called lactic acidosis can occur, characterized by symptoms such as rapid breathing, muscle pain, weakness, and abdominal discomfort. This requires immediate medical attention.
• Liver Function: Elevations in liver enzymes may occur in some individuals. Regular liver function tests are recommended during treatment.
• Immune Reconstitution Inflammatory Syndrome (IRIS): In some cases, individuals starting antiretroviral therapy, including Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets, may experience an immune response against previously undiagnosed infections. This is known as IRIS and requires careful monitoring and management.
• Drug Interactions: These tablets may interact with other medications, potentially affecting their effectiveness or leading to increased side effects. It’s essential to inform healthcare providers about all medications being taken.
• Allergic Reactions: Although rare, allergic reactions can occur, leading to symptoms such as skin rash, itching, or swelling.

It’s important to remember that the benefits of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets often outweigh the potential side effects, especially in the context of HIV treatment and prevention. Healthcare providers carefully assess the risks and benefits for each patient and closely monitor for adverse effects during treatment. Patients receiving this medication should communicate any concerning symptoms to their healthcare team promptly.

Frequently Asked Questions About Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets:

Certainly, here are some frequently asked questions (FAQs) about Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets:

1. What is the purpose of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets?

These tablets are used for the treatment of HIV infection. They are also used as preexposure prophylaxis (PrEP) to prevent HIV transmission in high-risk individuals.

2. How do I take these tablets?

Typically, they are taken orally as a single tablet once a day, with or without food. It’s important to follow your healthcare provider’s instructions for dosing.

3. Can I take these tablets with other medications or supplements?

Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets may interact with other medications or supplements. Inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

4. What should I do if I miss a dose?

If you miss a dose, take it as soon as you remember. If it is close to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double dose.

5. What are the common side effects of these tablets?

Common side effects may include CNS effects (e.g., vivid dreams, dizziness), nausea, diarrhea, mild gastrointestinal discomfort, and, less commonly, renal effects. However, side effects can vary from person to person.

6. How effective are these tablets in preventing HIV transmission as PrEP?

When taken consistently and as prescribed, these tablets are highly effective at reducing the risk of HIV infection in individuals at high risk.

7. Are there any long-term effects of taking these tablets?

Long-term use of tenofovir, one of the components, may lead to reduced bone mineral density in some individuals. Regular monitoring and discussion with a healthcare provider are essential.

8. Can I drink alcohol while taking these tablets?

It’s generally recommended to limit alcohol consumption while taking these tablets, as alcohol may increase the risk of CNS side effects associated with Efavirenz.

9. Is it safe to take these tablets during pregnancy?

The safety of these tablets during pregnancy should be discussed with a healthcare provider. In some cases, they may be recommended to prevent mother-to-child transmission.

10. Can I stop taking these tablets once my viral load is undetectable?

It’s important not to stop HIV treatment without consulting a healthcare provider. Stopping treatment can lead to viral rebound and a decline in immune function.

Always consult with a healthcare professional for personalized information and guidance regarding Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets, including their use, potential side effects, and interactions.

As Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets Exporters; We can cater to export business queries from the following geographies. We are exporting our Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets product in the Following Countries-

Russia and CIS Countries: Azerbaijan, Armenia, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Turkmenistan, Uzbekistan and Ukraine

GCC/ Middle East Countries: Saudi Arabia, Yemen, Oman, Bahrain, UAE, Lebanon, Jordan, and Iraq.

African Countries: Nigeria, Tanzania, Sudan, Zambia, Benin, Angola, Liberia

Southeast Asia: Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Brunei Darussalam

Other Asian Countries: Nepal, Myanmar, Malaysia, Cambodia, Bhutan, Sri Lanka, Mauritius

Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets Regulatory Documents:

• Certificate of Analysis (COA)
• Method of Analysis (MOA)
• Stability Data (Accelerated stability / Long-term stability / Zone 4b)
• CTD Dossier / ACTD Dossiers / eCTD Dossiers
• Certificate of Pharmaceuticals Product (COPP)
• Free Sale Certificate (FSC)

Contact the most reliable manufacturer of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets, Taj Pharmaceuticals Limited, to get bulk quantities at a reasonable price.

To Place Orders:

Direct line: +91 8448 444 095 / WhatsApp +91 74 0000 9975 / 74 0000 9976
E-Mail: info@tajpharma.com 
Toll free: 1-800-222-434 / Toll free: 1-800-222-825
General EPA BX: +91 22 2637 4592 / +91 22 2637 4593